tykhr
sign in
free sign up
Quince Therapeutics, Inc.
Biotechnology
Healthcare
QNCX
43.94 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.58
52 week high
2.16
high
1.64
52 week low
0.00
low
1.58
growth
0.00 %
previous Close
1.62
P/E ratio
market cap
88.48 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top